Streetbeat News

Stock Prices

IYE

XLE

XOM

Exxon Mobil Corporation (NYSE:XOM) has decided not to pursue a $10 billion oil field opportunity in Namibia, leading to a premarket share increase. The Mopane discovery, with an estimated 10 billion barrels of oil and gas, still attracts interest from other major oil companies. Meanwhile, Exxon has partnered with ADNOC for a low-carbon project in Texas.

Portfolio Pulse from Lekha Gupta

September 09, 2024 | 12:41 pm

TCBP

TC BioPharm is set to begin preclinical studies for its lead therapy, TCB 008, aimed at treating monkeypox. This development could potentially position the company as a key player in addressing the monkeypox outbreak.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:40 pm

QNRX

Quoin Pharmaceuticals' CEO and COO have made significant insider purchases of the company's ADSs, indicating strong confidence in the company's growth and direction. This move suggests a positive outlook for Quoin's future as it focuses on treatments for rare and orphan diseases.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:40 pm

HOVR

Horizon Aircraft is advancing its development of eVTOL aircraft by accelerating flight tests and expanding its team. This progress could impact companies involved in the eVTOL industry.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:40 pm

BNRG

Brenmiller Energy's shares rose following the announcement of raising $2 million through an equity offering and securing a $1.05 million private placement.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:39 pm

IBRX

ImmunityBio, Inc. (IBRX) presented promising Phase 2 data at the World Conference on Lung Cancer, showing prolonged survival in NSCLC patients using ANKTIVA with checkpoint inhibitors. The data supports Phase 3 trials and potential global launch.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:36 pm

RLAY

Relay Therapeutics shares are experiencing an increase in value following the release of interim data for its breast cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:34 pm

INBS

Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary unaudited revenue for Q4 and FY24, showing significant growth of 64% and 148% year-over-year, respectively. The company also anticipates increases in cartridge and reader sales.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:34 pm

AAPL

Apple is set to launch the iPhone 16, with a focus on pricing strategies to offset rising chip and memory costs. JPMorgan analyst Samik Chatterjee suggests a staggered pricing approach, maintaining prices for base models while increasing prices for Pro models. The integration of AI features and iOS 18 is expected to drive consumer interest.

Portfolio Pulse from Surbhi Jain

September 09, 2024 | 12:27 pm

RXO

RXO has announced a $350 million common stock offering, with an option for underwriters to purchase an additional $52.5 million in shares. This move is likely aimed at raising capital for the company.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:20 pm